Sean Godbout - Mar 1, 2025 Form 3 Insider Report for BIOGEN INC. (BIIB)

Role
Chief Accounting Officer
Signature
/s/ Samuel Ntonme, attorney-in-fact for Mr. Godbout
Stock symbol
BIIB
Transactions as of
Mar 1, 2025
Transactions value $
$0
Form type
3
Date filed
3/10/2025, 04:08 PM
Next filing
Apr 3, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BIIB Common Stock 310 Mar 1, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BIIB Restricted Stock Unit Mar 1, 2025 Common Stock 1.55K $0.00 Direct F1
holding BIIB Restricted Stock Unit Mar 1, 2025 Common Stock 610 $0.00 Direct F2
holding BIIB Restricted Stock Unit Mar 1, 2025 Common Stock 53 $0.00 Direct F3
holding BIIB Restricted Stock Unit Mar 1, 2025 Common Stock 257 $0.00 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 02/06/2025.
F2 The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 02/07/2024.
F3 The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 10/02/2023.
F4 The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 02/08/2023.